Aker Solutions' revenue rose 43% in the fourth quarter of 2024, and the company expects a solid order backlog in 2025 ...

Aker Solutions delivered strong revenue growth with improved margins in 2024. The order backlog remains solid at NOK 61 billion and the tender pipeline ...

Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” ...

Innoviz Technologies faces financial challenges and lack of profitability in the competitive automotive industry. Read why I ...

Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

The crypto market is on the brink of another major rally, and experienced investors know that positioning early is the key to ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.